Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Yi Li
Kaoru Toyama
Takafumi Nakatsu
Hitoshi Ishizuka
Hailan Wu
Guoying Cao
Jicheng Yu
Yu Wang
Xiaofen Liu
Beining Guo
Jufang Wu
Peimin Yu
Zhen Hong
Jing Zhang
Xiaojie Wu
机构：
[1] Huashan Hospital,Institute of Antibiotics
[2] Fudan University,Phase I Clinical Research Center
[3] Key Laboratory of Clinical Pharmacology of Antibiotics,Department of Neurology
[4] National Population and Family Planning Commission,undefined
[5] Daiichi Sankyo Co.,undefined
[6] Ltd.,undefined
[7] Huashan Hospital,undefined
[8] Fudan University,undefined
[9] Fudan University,undefined
来源：
Advances in Therapy | 2023年 / 40卷 / 4期
关键词：
China; Neuropathic pain; Mirogabalin; Multiple-dose; Pharmacokinetics; Phase I; Post-herpetic neuralgia; Safety; Single-dose; Tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1628 / 1643
页数：15
相关论文
共 50 条
  • [1] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Li, Yi
    Toyama, Kaoru
    Nakatsu, Takafumi
    Ishizuka, Hitoshi
    Wu, Hailan
    Cao, Guoying
    Yu, Jicheng
    Wang, Yu
    Liu, Xiaofen
    Guo, Beining
    Wu, Jufang
    Yu, Peimin
    Hong, Zhen
    Zhang, Jing
    Wu, Xiaojie
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
  • [2] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
    Zhao, Xue
    Liu, Hongzhong
    Tian, Wei
    Fang, Ligang
    Yu, Mengyang
    Wu, Xiaofei
    Liu, Aijing
    Wan, Ruijie
    Li, Li
    Luo, Jinghui
    Li, Yuqiong
    Liu, Bo
    He, Yu
    Chen, Xiaowen
    Li, Yuan
    Xu, Donghong
    Wang, Hongyun
    Han, Xiaohong
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers
    Jansen, Mendel
    Warrington, Steven
    Dishy, Victor
    Ohwada, Shoichi
    Johnson, Lisa
    Brown, Karen
    Ishizuka, Hitoshi
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669
  • [4] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy SubjectsA Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Michael Derks
    Judith Anzures-Cabrera
    Lynn Turnbull
    Mary Phelan
    [J]. Clinical Drug Investigation, 2011, 31 : 325 - 335
  • [5] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects A Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Derks, Michael
    Anzures-Cabrera, Judith
    Turnbull, Lynn
    Phelan, Mary
    [J]. CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 325 - 335
  • [6] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
  • [7] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
    Osterberg, O.
    Ivkovic, J.
    Sundgreen, C.
    Muglia, P.
    Prang, A.
    Darpo, B.
    [J]. NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
  • [8] Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
    Newman, Joseph, V
    Zhou, Jian
    Izmailyan, Sergey
    Tsai, Larry
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [9] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Haiyan Li
    Yudong Wei
    Zhenhua Yang
    Shuang Zhang
    Xiuxiu Xu
    Mengmeng Shuai
    Olivier Vitse
    Yiwen Wu
    Marie T. Baccara-Dinet
    Yi Zhang
    Jianyong Li
    [J]. American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
  • [10] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Li, Haiyan
    Wei, Yudong
    Yang, Zhenhua
    Zhang, Shuang
    Xu, Xiuxiu
    Shuai, Mengmeng
    Vitse, Olivier
    Wu, Yiwen
    Baccara-Dinet, Marie T.
    Zhang, Yi
    Li, Jianyong
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 489 - 503
12345